View in EDS PDF Full Text

Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.

Saved in:
Bibliographic Details
Title: Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
Authors: Meeks SL; Aflac Cancer Center and Blood Disorders Center at Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Lacroix-Desmazes S; Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 Nov; Vol. 26 (6), pp. 958-965. Date of Electronic Publication: 2020 Sep 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32885562
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meeks+SL%22">Meeks SL</searchLink>; Aflac Cancer Center and Blood Disorders Center at Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lacroix-Desmazes+S%22">Lacroix-Desmazes S</searchLink>; Centre de recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229442916%22">Haemophilia : the official journal of the World Federation of Hemophilia</searchLink> [Haemophilia] 2020 Nov; Vol. 26 (6), pp. 958-965. <i>Date of Electronic Publication: </i>2020 Sep 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9442916 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2516 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213518216%22">13518216 </searchLink><i>NLM ISO Abbreviation: </i>Haemophilia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32885562
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/hae.14123
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 958
    Titles:
      – TitleFull: Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meeks SL
      – PersonEntity:
          Name:
            NameFull: Lacroix-Desmazes S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2020 Nov
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2516
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Haemophilia : the official journal of the World Federation of Hemophilia
              Type: main
ResultId 1